Investigational epigenetic therapy lowers incidence of MACE in phase 2b study
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- AHA 2024
Perspectives on CKM syndrome
Javed Butler, MD
Ulrich Laufs, MD, PhD
Ulrich Laufs, MD, PhD
Paul Ridker, MD
Stephen Nicholls, MD